Title : Donafenib: First Approval.

Pub. Date : 2021 Nov

PMID : 34591285






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Donafenib (Zepsun , ), a deuterium derivative of sorafenib, is an oral small molecule multikinase inhibitor of multiple receptor kinases, including vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and Raf kinases. Sorafenib kinase insert domain receptor Homo sapiens